C20 Ceramide

CAS No. 7344-02-7

C20 Ceramide( —— )

Catalog No. M35232 CAS No. 7344-02-7

C20 Ceramide (N-Arachidoyl-D-sphingosine) is a 20:0 ceramide found in the brain that crosses the blood-brain barrier to activate microglia and induce depressive-like behavior.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 49 In Stock
5MG 68 In Stock
10MG 100 In Stock
25MG 162 In Stock
50MG 237 In Stock
100MG 347 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    C20 Ceramide
  • Note
    Research use only, not for human use.
  • Brief Description
    C20 Ceramide (N-Arachidoyl-D-sphingosine) is a 20:0 ceramide found in the brain that crosses the blood-brain barrier to activate microglia and induce depressive-like behavior.
  • Description
    C20 Ceramide is a natural 20:0 ceramide that is abundant in the brain.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Proteasome/Ubiquitin
  • Target
    Endogenous Metabolite
  • Recptor
    Endogenous Metabolite
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    7344-02-7
  • Formula Weight
    594.01
  • Molecular Formula
    C38H75NO3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [C@@H](NC(CCCCCCCCCCCCCCCCCCC)=O)([C@@H](/C=C/CCCCCCCCCCCCC)O)CO
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Cowart LA. Sphingolipids: players in the pathology of metabolic disease. Trends Endocrinol Metab. 2009 Jan;20(1):34-42.?
molnova catalog
related products
  • (L)-Dehydroascorbic ...

    L-Dehydro Ascorbic Acid is the reversibly oxidized form of ascorbic acid;Dehydroascorbic acid a blood-brain barrier transportable form of vitamin C mediates potent cerebroprotection in experimental stroke.

  • 5'-Guanylic acid

    5'-Guanylic acid is involved in several metabolic disorders, including AICA-ribosiduria pathway, ?adenosine deaminase deficiency,adenine phosphoribosyltransferase deficiency (aprt), and the 2-hydroxyglutric aciduria pathway.

  • Cytosine

    Cytosine is a pyrimidine base that is a fundamental unit of nucleic acids. The deamination of cytosine alone is apparent and the nucleotide of cytosine is the prime mutagenic nucleotide in leukaemia and cancer.